ASP5878   Click here for help

GtoPdb Ligand ID: 11934

Synonyms: ASP-5878 | compound 27 [PMID: 35219181]
Compound class: Synthetic organic
Comment: ASP5878 is an investigational, oral pan-FGFR inhibitor that was developed for potential to combat solid tumours [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 103.55
Molecular weight 407.14
XLogP 1.64
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCn1ncc(c1)Nc1ncc(cn1)OCc1c(F)c(OC)cc(c1F)OC
Isomeric SMILES COc1cc(c(c(c1F)COc1cnc(nc1)Nc1cn(nc1)CCO)F)OC
InChI InChI=1S/C18H19F2N5O4/c1-27-14-5-15(28-2)17(20)13(16(14)19)10-29-12-7-21-18(22-8-12)24-11-6-23-25(9-11)3-4-26/h5-9,26H,3-4,10H2,1-2H3,(H,21,22,24)
InChI Key VDZZYOJYLLNBTD-UHFFFAOYSA-N
References
1. Kikuchi A, Suzuki T, Nakazawa T, Iizuka M, Nakayama A, Ozawa T, Kameda M, Shindoh N, Terasaka T, Hirano M et al.. (2017)
ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.
Cancer Sci, 108 (2): 236-242. [PMID:27885740]
2. Kuriwaki I, Kameda M, Iikubo K, Hisamichi H, Kawamoto Y, Kikuchi S, Moritomo H, Terasaka T, Iwai Y, Noda A et al.. (2022)
Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity.
Bioorg Med Chem, 59: 116657. [PMID:35219181]